171 related articles for article (PubMed ID: 34926792)
1. Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche.
Peters EB; Karver MR; Sun K; Gillis DC; Biswas S; Clemons TD; He W; Tsihlis ND; Stupp SI; Kibbe MR
Adv Ther (Weinh); 2021 Sep; 4(9):. PubMed ID: 34926792
[TBL] [Abstract][Full Text] [Related]
2. Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery.
Peters EB; Tsihlis ND; Karver MR; Chin SM; Musetti B; Ledford BT; Bahnson EM; Stupp SI; Kibbe MR
Adv Healthc Mater; 2019 Feb; 8(3):e1801545. PubMed ID: 30620448
[TBL] [Abstract][Full Text] [Related]
3. Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis.
Mansukhani NA; Peters EB; So MM; Albaghdadi MS; Wang Z; Karver MR; Clemons TD; Laux JP; Tsihlis ND; Stupp SI; Kibbe MR
Macromol Biosci; 2019 Jun; 19(6):e1900066. PubMed ID: 31066494
[TBL] [Abstract][Full Text] [Related]
4. Peptide Amphiphile Nanostructures for Targeting of Atherosclerotic Plaque and Drug Delivery.
So MM; Mansukhani NA; Peters EB; Albaghdadi MS; Wang Z; Pérez CMR; Kibbe MR; Stupp SI
Adv Biosyst; 2018 Mar; 2(3):. PubMed ID: 30666317
[TBL] [Abstract][Full Text] [Related]
5. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
[No Abstract] [Full Text] [Related]
7. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.
Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F
J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093
[TBL] [Abstract][Full Text] [Related]
8. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
9. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies.
Ozasa H; Ayaori M; Iizuka M; Terao Y; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Uehara Y; Ogura M; Sasaki M; Komatsu T; Horii S; Mochizuki S; Yoshimura M; Ikewaki K
Atherosclerosis; 2011 Nov; 219(1):141-50. PubMed ID: 21862012
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus acidophilus K301 Inhibits Atherogenesis via Induction of 24 (S), 25-Epoxycholesterol-Mediated ABCA1 and ABCG1 Production and Cholesterol Efflux in Macrophages.
Hong YF; Kim H; Kim HS; Park WJ; Kim JY; Chung DK
PLoS One; 2016; 11(4):e0154302. PubMed ID: 27120199
[TBL] [Abstract][Full Text] [Related]
12. Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages.
Jiang Z; Sang H; Fu X; Liang Y; Li L
Biotechnol Appl Biochem; 2015; 62(6):840-7. PubMed ID: 25496323
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-based "Two-pronged" approach to regress atherosclerosis by simultaneous modulation of cholesterol influx and efflux.
He H; Wang J; Yannie PJ; Korzun WJ; Yang H; Ghosh S
Biomaterials; 2020 Nov; 260():120333. PubMed ID: 32853832
[TBL] [Abstract][Full Text] [Related]
14. Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.
Guo Y; Yuan W; Yu B; Kuai R; Hu W; Morin EE; Garcia-Barrio MT; Zhang J; Moon JJ; Schwendeman A; Eugene Chen Y
EBioMedicine; 2018 Feb; 28():225-233. PubMed ID: 29361501
[TBL] [Abstract][Full Text] [Related]
15. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.
Ramírez CM; Rotllan N; Vlassov AV; Dávalos A; Li M; Goedeke L; Aranda JF; Cirera-Salinas D; Araldi E; Salerno A; Wanschel A; Zavadil J; Castrillo A; Kim J; Suárez Y; Fernández-Hernando C
Circ Res; 2013 Jun; 112(12):1592-601. PubMed ID: 23519695
[TBL] [Abstract][Full Text] [Related]
16. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists.
Levin N; Bischoff ED; Daige CL; Thomas D; Vu CT; Heyman RA; Tangirala RK; Schulman IG
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):135-42. PubMed ID: 15539622
[TBL] [Abstract][Full Text] [Related]
17. DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux-an LXR-dependent mechanism.
Zhang L; Jiang M; Shui Y; Chen Y; Wang Q; Hu W; Ma X; Li X; Liu X; Cao X; Liu M; Duan Y; Han J
Biochim Biophys Acta; 2013 Jun; 1831(6):1134-45. PubMed ID: 23466610
[TBL] [Abstract][Full Text] [Related]
18. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
Shridas P; Bailey WM; Gizard F; Oslund RC; Gelb MH; Bruemmer D; Webb NR
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2014-21. PubMed ID: 20844270
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase A2 group IIA correlates with circulating high-density lipoprotein cholesterol and modulates cholesterol efflux possibly through regulation of PPAR-γ/LXR-α/ABCA1 in macrophages.
Liang L; Xie Q; Sun C; Wu Y; Zhang W; Li W
J Transl Med; 2021 Nov; 19(1):484. PubMed ID: 34838043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
